GVK locks down contract extension with FDA; PwC: Industry faces R&D talent gap;

> The FDA has extended its license of GVK Biosciences' biomarker database, which it uses in its biomarker qualification process. News

> PerkinElmer ($PKI) narrowed its losses in the fourth quarter, thanks in part to a 6% revenue jump in its human health unit. Article

> There's a talent gap in the biopharma world, according to PricewaterhouseCoopers, making it hard for companies in the industry to find hirable R&D workers. That's led to a whole host of innovative approaches, including academic partnerships and crowdsourcing. More

> CMO Lonza is suggesting cutbacks in its manufacturing division, planning to "move from a product-oriented to a market-oriented organization." Story

> CRO ClinPharm Consulting has changed its name to Kinetigen, saying the switch reflects its expanded role in the industry and evolution into a pharmacology and pharmacokinetics operation. Item